neopterin
creactiv
protein
crp
concentr
determin
serum
sampl
sever
acut
respiratori
syndrom
sar
patient
healthi
blood
donor
patient
confirm
sar
earli
neopterin
elev
detect
alreadi
day
onset
symptom
rose
maximum
level
nmoll
day
onset
sar
patient
elev
neopterin
concentr
nmoll
within
day
onset
mean
neopterin
concentr
nmoll
acut
sera
sar
patient
nmoll
convalesc
sera
nmoll
healthi
control
contrast
mean
crp
concentr
acut
convalesc
sera
sar
patient
normal
rang
mgl
serum
neopterin
level
sar
patient
associ
fever
period
thu
clinic
progress
diseas
signific
correl
crp
level
fever
period
serum
neopterin
may
allow
earli
assess
sever
sar
decreas
neopterin
level
found
steroid
treatment
indic
blood
sampl
collect
steroid
treatment
neopterin
measur
time
initi
outbreak
sever
acut
respiratori
syndrom
sar
case
diagnos
death
attribut
sar
worldwid
see
front
matter
elsevi
inc
right
reserv
diseas
first
emerg
china
prove
highli
contagi
spread
hong
kong
taiwan
singapor
philippin
viet
nam
canada
unit
state
countri
countri
experienc
brunt
outbreak
health
care
worker
primari
popul
risk
contract
sar
novel
coronaviru
sarscov
identifi
etiolog
agent
sar
viru
caus
similar
diseas
cynomolg
macaqu
gener
sar
begin
high
fever
headach
overal
feel
discomfort
bodi
ach
peopl
also
experi
mild
respiratori
symptom
day
sar
patient
may
develop
dri
cough
short
breath
patient
clinic
featur
vari
subclin
mild
sever
situat
diseas
cours
might
day
week
month
treatment
sar
includ
antivir
drug
steroid
demonstr
administr
high
dose
methylprednisolon
corticosteroid
associ
clinic
improv
especi
subset
sar
patient
sever
pneumonia
howev
longterm
side
effect
high
dose
steroid
report
today
clinic
laboratori
judgment
accur
use
specul
diseas
progress
evalu
need
steroid
treatment
immun
respons
eg
trigger
viral
infect
molecular
weight
da
gener
releas
increas
amount
human
macrophag
upon
activ
interferong
accordingli
determin
neopterin
concentr
bodi
fluid
use
monitor
cellular
immun
activ
variou
diseas
infect
autoimmun
diseas
malign
disord
earli
detect
allograft
reject
episod
particular
increas
neopterin
concentr
blood
urin
earli
sensit
indic
presenc
broad
panel
viral
infecti
diseas
includ
human
immunodefici
viru
type
degre
neopterin
elev
eg
patient
infect
predict
valu
acut
infect
cytomegaloviru
rubella
increas
neopterin
concentr
observ
specif
antibodi
becam
detect
howev
increas
neopterin
concentr
specif
viru
infect
sinc
almost
sar
case
associ
pneumonia
inflamm
lung
neopterin
level
earli
stage
sar
may
sensit
indic
estim
sever
diseas
confirm
hypothesi
detect
concentr
neopterin
serum
sampl
collect
confirm
sar
patient
sera
healthi
blood
donor
result
show
level
neopterin
markedli
increas
acut
infect
sarscov
earli
first
day
onset
return
normal
level
convalesc
period
also
found
higher
level
neopterin
associ
longer
fever
period
patient
nevertheless
neopterin
level
patient
relat
specif
antibodi
respons
evalu
potenti
clinic
signific
neopterin
sar
patient
studi
case
admit
hospit
guangzhou
china
januari
may
seventythre
health
care
worker
hospit
case
diagnos
atyp
pneumonia
confirm
chest
xray
examin
match
definit
sar
describ
world
health
organ
center
diseas
control
prevent
cdc
diagnosi
sar
confirm
serolog
also
virolog
clinic
inform
sar
patient
summar
tabl
total
nasopharyng
aspir
npa
throat
swab
ts
specimen
sar
patient
collect
viru
isol
identif
specimen
store
viral
transport
medium
least
pair
sera
taken
sar
patient
antibodi
neopterin
creactiv
protein
crp
detect
acut
sera
collect
within
day
onset
diseas
convalesc
sera
collect
day
onset
addit
serum
sampl
subsequ
obtain
patient
total
serum
sampl
sar
patient
recruit
studi
serum
sampl
also
collect
healthi
adult
blood
bank
red
cross
hong
kong
sera
guangzhou
sera
control
serum
sampl
store
presenc
sarscov
identifi
revers
transcript
polymeras
chain
reaction
rtpcr
describ
briefli
viral
rna
extract
npa
ts
sampl
rnesay
mini
kit
qiagen
chatsworth
ca
first
strand
cdna
synthes
use
rna
h
revers
transcriptas
life
technolog
inc
md
random
primer
subsequ
pcr
carri
use
seri
primer
pcr
kit
invitrogen
corp
ca
npa
sampl
also
inocul
fetal
rhesu
kidney
cell
scov
describ
sar
viru
isol
strain
viru
isol
character
sera
heat
inactiv
min
test
dilut
presenc
antisar
viru
antibodi
use
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
ifa
elisa
perform
use
elisa
kit
detect
sar
virusspecif
igg
antibodi
beij
gbi
biotech
co
ltd
china
accord
manufactur
instruct
vero
vero
cell
infect
human
sar
cov
strain
fix
aceton
min
use
antigen
ifa
detect
virusspecif
antibodi
uninfect
cell
appli
experi
neg
control
ifa
carri
describ
posit
sera
antibodi
titer
determin
serial
twofold
titrat
serum
neopterin
determin
use
commerci
avail
elisa
elitest
neopterinscreen
brahm
diagnostica
berlin
germani
accord
manufactur
instruct
sensit
nmol
neopterin
l
refer
level
healthi
control
set
nmoll
crp
concentr
serum
sampl
determin
use
modifi
convent
enzymelink
immunosorb
assay
antigen
captur
type
sandwich
elisa
catcher
detector
monoclon
antibodi
purchas
hytest
ltd
finland
catcher
antibodi
direct
crp
coat
microtit
plate
immulon
hb
flat
bottom
dynex
technolog
inc
moll
carbon
buffer
ph
overnight
step
perform
room
temperatur
pbt
mm
phosphatebuff
salin
ph
supplement
wtvol
bovin
plasma
albumin
bsa
volvol
step
plate
wash
five
time
pbt
coat
wash
al
sampl
standard
contain
crp
hytest
ltd
finland
incub
half
hour
gentl
shake
allow
crp
bind
antibodi
attach
plate
plate
wash
al
detector
antibodi
conjug
horseradish
peroxidas
incub
half
hour
gentl
shake
al
substrat
mixtur
arista
biolog
inc
pa
usa
contain
tetramethylbenzidin
tmb
hydrogen
peroxid
h
ad
well
enzym
reaction
stop
within
min
al
sulphur
acid
percentil
small
squar
g
denot
mean
dash
denot
maximum
minimum
valu
differ
neopterin
concentr
group
statist
signific
p
mann
whitney
test
absorb
nm
measur
use
microtit
plate
reader
dynatech
medic
product
limit
guernsey
calibr
curv
linear
mgl
detect
limit
assay
mgl
obtain
less
interand
intraassay
verif
refer
level
healthi
control
set
mgl
data
indic
mean
sd
plot
neopterin
concentr
versu
time
admiss
present
mean
sem
mann
whitney
test
use
assess
statist
signific
differ
level
signific
set
p
serum
neopterin
level
rais
sar
patient
earli
first
day
onset
symptom
nmoll
reach
mean
concentr
nmoll
mean
sd
rang
nmoll
acut
sera
fig
contrast
serum
neopterin
level
normal
nmoll
either
convalesc
sera
sar
patient
nmoll
serum
sampl
healthi
blood
donor
nmoll
median
serum
neopterin
concentr
fivefold
higher
acut
sera
sar
patient
convalesc
sera
vs
nmoll
p
fig
fourfold
higher
healthi
blood
donor
vs
nmoll
p
fig
hand
mean
crp
concentr
acut
sar
sera
mgl
refer
level
mgl
also
serum
crp
level
convalesc
sar
sera
similar
healthi
subject
shown
fig
neopterin
concentr
elev
day
onset
nmoll
mean
sem
reach
peak
valu
nmoll
day
howev
crp
concentr
slightli
elev
day
mgl
serum
neopterin
maintain
high
level
nmoll
day
onset
return
normal
level
nmoll
day
onset
maintain
low
level
studi
period
month
analyz
clinic
signific
increas
neopterin
earli
stage
sar
patient
compar
patient
neopterin
level
differ
day
day
onset
fever
period
found
higher
neopterin
level
patient
longer
fever
period
experienc
fig
patient
longer
fever
period
also
appear
sever
diseas
progress
includ
higher
fever
sever
short
breath
longer
hospit
period
complic
tabl
result
suggest
higher
neopterin
level
may
earli
sign
patient
suffer
sever
sar
contrast
correl
serum
crp
level
fever
period
studi
sar
patient
recov
discharg
hospit
sinc
neopterin
indic
cellular
immun
respons
variou
diseas
compar
level
neopterin
sarscovspecif
antibodi
patient
result
show
signific
correl
neopterin
level
antibodi
level
determin
ifa
patient
fig
compar
neopterin
concentr
acut
sera
taken
sar
patient
receiv
steroid
treatment
treat
steroid
found
neopterin
level
acut
sera
obtain
patient
accept
steroid
significantli
higher
collect
patient
treat
steroid
day
onset
fig
result
show
treatment
steroid
might
suppress
gener
neopterin
sar
patient
therefor
blood
sampl
collect
steroid
treatment
neopterin
measur
first
studi
show
increas
serum
neopterin
concentr
sar
patient
earli
first
day
onset
symptom
signific
differ
neopterin
concentr
acut
sar
sera
nmoll
mean
sd
either
convalesc
sar
sera
nmoll
healthi
blood
donor
nmoll
sar
patient
elev
neopterin
concentr
nmoll
within
day
onset
contrast
mean
crp
concentr
acut
convalesc
sar
sera
found
refer
level
mgl
kinet
neopterin
concentr
base
sar
patient
indic
earli
neopterin
elev
detect
alreadi
day
onset
symptom
quickli
reach
peak
level
day
onset
neopterin
concentr
maintain
high
level
day
onset
prevent
fals
neg
result
observ
fit
well
data
obtain
viru
infect
hiv
rubella
also
ebola
agre
result
eg
experiment
infect
rhesu
macaqu
simian
immunodefici
viru
siv
data
avail
primarili
studi
infect
impli
predict
valu
neopterin
concentr
might
exist
also
patient
sar
lower
neopterin
concentr
like
recov
other
notabl
behavior
neopterin
concentr
acut
sar
patient
similar
cytomegaloviru
cmv
rubella
infect
differ
consider
patient
anim
siv
infect
like
sar
patient
acut
cmv
rubella
infect
caus
sharp
increas
neopterin
concentr
follow
seroconvers
drop
neopterin
concentr
rang
healthi
control
tabl
relationship
fever
period
clinic
statu
sar
patient
higher
neopterin
concentr
crp
concentr
sar
patient
associ
longer
fever
period
thu
sever
cours
diseas
show
neopterin
earli
indic
sever
sar
clinic
progress
sar
describ
triphas
pattern
increas
neopterin
level
sar
patient
phase
prior
seroconvers
indic
increas
activ
cellular
immun
system
primarili
due
effect
viral
replic
cytolysi
symptom
gener
improv
day
diseas
progress
phase
ii
neopterin
level
return
refer
rang
seroconvers
lung
damag
phase
relat
immunopatholog
damag
result
exuber
host
respons
rather
uncontrol
viral
replic
therefor
correl
neopterin
level
antibodi
titer
recurr
fever
onset
diarrhea
oxygen
desatur
shift
radiograph
shadow
occur
phase
iii
character
acut
respiratori
distress
syndrom
ard
necessit
ventilatori
support
patient
may
develop
nosocomi
sepsi
phase
endorgan
damag
sever
lymphopenia
minim
risk
progress
chronic
phase
ard
side
effect
steroid
treatment
earli
assess
sever
sar
critic
treatment
design
use
neopterin
quantifi
sever
sar
patient
receiv
proper
medic
treatment
earli
stage
thu
produc
good
recoveri
rate
contribut
consider
econom
gain
patient
hospit
minim
risk
infect
transmiss
serum
neopterin
level
significantli
lower
sar
patient
steroid
therapi
without
treatment
fig
impli
neopterin
level
may
use
marker
inflammatori
activ
sar
proinflammatori
cytokin
releas
stimul
macrophag
alveoli
promin
role
pathogenesi
sar
result
cytokin
dysregul
use
steroid
treatment
sar
patient
modul
cytokin
respons
prevent
fatal
outcom
howev
steroid
may
lead
perman
suppress
cellular
immun
reaction
associ
cell
thu
increas
suscept
infect
opportunist
germ
stratifi
patient
accord
sever
diseas
suitabl
dosag
steroid
appli
minim
major
side
effect
interestingli
use
neopterin
monitor
classifi
patient
steroid
therapi
alreadi
suggest
patient
sarcoidosi
neopterin
concentr
healthi
control
mean
sd
nmoll
compar
data
literatur
nmoll
albeit
slightli
higher
howev
number
specimen
healthi
control
test
studi
still
low
interestingli
neopterin
concentr
sera
collect
convalesc
patient
nmoll
even
better
fit
healthi
european
control
patient
chronic
renal
failur
concentr
neopterin
serum
like
high
elev
longer
period
time
thu
caution
must
taken
use
neopterin
screen
sar
case
renal
insuffici
studi
requir
valid
refin
optim
serum
neopterin
cutoff
valu
diagnosi
prognosi
futur
work
address
relationship
neopterin
level
among
patient
sar
nonsar
pneumonia
effect
treatment
morbid
outcom
technolog
advanc
may
enhanc
use
neopterin
measur
acut
infect
present
use
neopterin
elisa
allow
result
avail
least
h
sampl
hand
measur
neopterin
concentr
also
perform
urinari
specimen
thu
develop
onestep
rapid
test
quantit
neopterin
analysi
urin
sampl
may
allow
time
reduc
min
noninvas
test
monitor
patient
present
sar
symptom
studi
first
report
neopterin
earli
marker
assess
sever
sar
elev
neopterin
level
detect
earli
first
day
onset
symptom
patient
elev
neopterin
concentr
nmoll
within
day
onset
sar
entir
new
emerg
diseas
clinic
cours
vari
wide
due
extrem
contagi
natur
diseas
singl
undetect
case
may
lead
widespread
transmiss
sar
test
hundr
suspect
sar
case
requir
day
outbreak
thu
sensit
simpl
rapid
noninvas
test
must
develop
particularli
effect
treatment
regim
avail
futur
